BioCentury
ARTICLE | Company News

Medicines Co., Mallinckrodt deal

February 8, 2016 8:00 AM UTC

The Medicines Co. (NASDAQ:MDCO), Parsippany, N.J. Mallinckrodt plc (NYSE:MNK), St. Louis, Mo. Business: Hematology The Medicines Co. divested its hemostasis portfolio to Mallinckrodt for $174 million...